National Dairy Development Board subsidiary Indian Immunologicals (IIL) will be investing about ₹700 crore to set up a new animal vaccine manufacturing facility in Genome Valley, Hyderabad.
The proposed facility will produce vaccines for FMD (Foot and Mouth disease) and other emerging diseases. It will create employment for around 750 people, the company said on Monday after its executive leadership met Industries and IT Minister K.T. Rama Rao.
The greenfield veterinary vaccine facility is intended to be a state-of-art fully integrated biosafety level 3 (BSL-3) facility for drug substance production and respective fill-finish, said IIL, which is one of the largest manufacturers of FMD vaccine globally and a leading supplier of the vaccine to the National Animal Disease Control Programme.
